Pregnancy outcome following high doses of Vitamin E supplementation

Reprod Toxicol. May-Jun 2005;20(1):85-8. doi: 10.1016/j.reprotox.2005.01.003.

Abstract

The recommended dose of Vitamin E in human pregnancy is 22-30 mg/day. High doses of Vitamin E (>or=400 IU/day) have been shown to attenuate or even prevent the damaging effect of ethanol and diabetes on the fetus in experimental animal models. The Motherisk program prospectively enrolled, and followed-up on, 82 pregnant women exposed to high doses (>or=400 IU/day) of Vitamin E during the first trimester of pregnancy. Pregnancy outcome was compared to a matched control group. The study group (n=82) was exposed to Vitamin E at doses ranging from 400-1200 IU/day. There was one pregnancy with major malformation (omphalocele) in study group. There was an apparent decrease in mean birth weight (3173+/-467 g) in Vitamin E group as compare to control (3417+/-565 g; P=0.0015); however, there were no significant differences in rates of live births, preterm deliveries, miscarriages and stillbirths. Therefore, it is concluded that consumption of high doses of Vitamin E during the first trimester of pregnancy does not appear to be associated with an increased risk for major malformations, but may be associated with decrease in birth weight.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antioxidants / adverse effects*
  • Birth Weight / drug effects
  • Canada / epidemiology
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Maternal Exposure / adverse effects*
  • Pregnancy
  • Pregnancy Outcome / epidemiology*
  • Pregnancy Trimester, First*
  • Prospective Studies
  • Vitamin E / administration & dosage*

Substances

  • Antioxidants
  • Vitamin E